Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study authors hypothesize that in patients with intestinal polyps, tumor cells could disseminate and circulating factors could be secreted by the polyp. These two parameters could become biomarkers to refine the follow-up of patients and to establish targeted therapeutic strategies.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with polyps |
| ||
| Patients without polyps |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Blood test | Other | Venous blood samples taken at the moment of colonoscopy to test for biomarkers |
|
| Measure | Description | Time Frame |
|---|---|---|
| Dissemination of circulating tumor cells in blood samples from patients with intestinal polyps compared to patients without polyps | Number of disseminated circulating tumor cells found on the ANGLE Parsortixâ„¢ system | Day 0 |
| Measure | Description | Time Frame |
|---|---|---|
| Concentration of Macrophage Colony Stimulating Factor (M-CSF) in the blood samples between groups | ng/mL, measured by Enzyme-Linked ImmunoSorbent Assay | Day 0 |
| Concentration of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in the blood samples between groups. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adult patients scheduled for colonoscopy in the Hepato-Gastro-Enterology Department of the University Hospital of Nîmes. Patients with a family history of colorectal cancer and aged over 50 years, with a positive Fecal Immunological Test, with bleeding, with abdominal pain or with unexplained anemia are all likely to undergo colonoscopy
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jean-François BOURGAUX | CHU de Nimes | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de Nîmes | Nîmes | France |
Not provided
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| D009362 | Neoplasm Metastasis |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
| ID | Term |
|---|---|
| D006403 | Hematologic Tests |
| ID | Term |
|---|---|
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Venous blood collected at time of colonoscopy
ng/mL, measured by Enzyme-Linked ImmunoSorbent Assay |
| Day 0 |
| Concentration of Chemokine ligand 2 (CCL-2) in the blood samples between groups. | ng/mL, measured by Enzyme-Linked ImmunoSorbent Assay | Day 0 |
| Concentration of keratinocyte-derived cytokine (CXCL-1) in the blood samples between groups | ng/mL, measured by Enzyme-Linked ImmunoSorbent Assay | Day 0 |
| Concentration of Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) in the blood samples between groups | ng/mL, measured by Enzyme-Linked ImmunoSorbent Assay | Day 0 |
| Concentration of Stromal cell-Derived Factor 1 (SDF-1) in the blood samples between groups | ng/mL, measured by Enzyme-Linked ImmunoSorbent Assay | Day 0 |
| Anti-aggregant therapy according to presence of circulating tumor cells, cytokine presence and presence of polyp | Yes/no | Day 0 |
| Anti-coagulant therapy according to presence of circulating tumor cells, cytokine presence and presence of polyp | Yes/no | Day 0 |
| Known intestinal pathology according to presence of circulating tumor cells, cytokine presence and presence of polyp | Yes/no | Day 0 |
| Reason for screening colonoscopy according to presence of circulating tumor cells, cytokine presence and presence of polyp | Fecal immunochemical test positive / Personal history of colonic adenoma / Family history of colonic adenoma / Personal history of colorectal cancer / Family history of colorectal cancer / Rectal symptoms | Day 0 |
| Screening colonoscopy operator (inter-operator tumor detection rate) according to presence of circulating tumor cells, cytokine presence and presence of polyp | Day 0 |
| Quality of the preparation according to presence of circulating tumor cells, cytokine presence and presence of polyp | Boston classification: ranked from 0 to 3 for each colonic segment explored | Day 0 |
| Caecal intubation rate according to presence of circulating tumor cells, cytokine presence and presence of polyp | classed as complete colonoscopy after visualization of the caecal floor | Day 0 |
| Per-surgical complications according to presence of circulating tumor cells, cytokine presence and presence of polyp | Post-polypectomy bleeding / Perforation / Incomplete colonoscopy / No complications | Day 0 |
| Total number of colonic adenomas visualized according to presence of circulating tumor cells, cytokine presence and presence of polyp | Number | Day 0 |
| Total number of histologically validated resected colonic adenomas according to presence of circulating tumor cells, cytokine presence and presence of polyp | Number | Day 0 |
| Size of resected adenomas according to presence of circulating tumor cells, cytokine presence and presence of polyp | < 5mm / 5 - 10mm / > 10mm | Day 0 |
| Location of resected adenomas according to presence of circulating tumor cells, cytokine presence and presence of polyp | Rectum / Sigmoid / Left Colon / Transverse Colon / Right Colon / Caecum | Day 0 |
| Morphology of resected adenomas according to presence of circulating tumor cells, cytokine presence and presence of polyp | Paris classification: 0-Is / 0-Ip / 0-IIa / 0-IIb / 0-IIc / 0-III | Day 0 |
| Method of resected adenomas according to presence of circulating tumor cells, cytokine presence and presence of polyp | Biopsy forceps / Cold loop / Diathermic loop / Mucosectomy / Unresected (Suspected Cancer, Unresectable in ambulatory) | Day 0 |
| Recovery of the adenoma after resection according to presence of circulating tumor cells, cytokine presence and presence of polyp | Yes/no | Day 0 |
| Histology of resected adenomas according to presence of circulating tumor cells, cytokine presence and presence of polyp | Vienna classification: Nonspecific (Food Residue, Normal Mucosa or Colonic Fold) / Adenoma in Low Grade Dysplasia / Adenoma in High Grade Dysplasia / Cancer - Transformed Adenoma / Scalloped Adenoma / Hyperplastic Polyp. | Day 0 |
| Location of resected adenomas according to presence of circulating tumor cells, cytokine presence and membrane marker expression | Rectum / Sigmoid / Left Colon / Transverse Colon / Right Colon / Caecum | Day 0 |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |
| D009385 | Neoplastic Processes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |